Benitec Biopharma (BNTC) Depreciation & Amortization (CF) (2019 - 2025)
Benitec Biopharma (BNTC) reported Depreciation & Amortization (CF) of $14000.0 for Q4 2025, little changed on a YoY basis from $14000.0 in Q4 2024, and up 7.69% sequentially from $13000.0 in Q3 2025.
Benitec Biopharma (BNTC) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $14000.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation & Amortization (CF) changed 0.0% year-over-year to $14000.0; the trailing twelve-month figure through Dec 2025 stood at $54000.0 (down 40.0% YoY), and the FY2025 full-year result was $66000.0, down 24.14% from the prior year.
- Depreciation & Amortization (CF) grew to $14000.0 in Q4 2025, from $13000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $67000.0 in Q1 2021 to a low of $6000.0 in Q2 2022.
- A 5-year average of $30100.0 and a median of $25000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) sank 88.46% in 2022 and jumped 250.0% in 2023, its largest moves.
- Tracing BNTC's Depreciation & Amortization (CF) over 5 years: stood at $55000.0 in 2021, then declined by 25.45% to $41000.0 in 2022, then slumped by 58.54% to $17000.0 in 2023, then dropped by 17.65% to $14000.0 in 2024, then changed by 0.0% to $14000.0 in 2025.
- Business Quant data shows BNTC's Depreciation & Amortization (CF) at $14000.0 in Q4 2025, $13000.0 in Q3 2025, and $14000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | 14,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14,000.00 |
| Dec 31, 2025 | 14,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Sep 30, 2023 | 19,000.00 |